Clinical Pharmacology Details


CARVEDILOL


View Drug Forms

Indications & Dose:

Hypertension



Adult: Initially 12.5 mg once daily for 2 days, then increased to 25 mg once daily; increased if necessary up to 50 mg daily, dose to be increased at intervals of at least 2 weeks and can be given as a single dose or in divided doses


Elderly: Initially 12.5 mg daily, initial dose may provide satisfactory control


Angina



Adult: Initially 12.5 mg twice daily for 2 days, then increased to 25 mg twice daily


Adjunct to diuretics, digoxin, or ACE inhibitors in symptomatic chronic heart failure  



Adult: Initially 3.125 mg twice daily, dose to be taken with food, then increased to 6.25 mg twice daily, then increased to 12.5 mg twice daily, then increased to 25 mg twice daily, dose should be increased at intervals of at least 2 weeks up to the highest tolerated dose, max. 25 mg twice daily in patients with severe heart failure or body-weight less than 85 kg;


 

Contraindications:

Bronchial  asthma,cardiogenic shock, overt cardiac failure, second and third degree AV block, severe sinus bradycardia


 

Side Effects:

CNS: Dizziness


CV: AV block, bradycardia (2%), CHF, postural hypotension (1.8%), syncope (0.1 %)


GI: Elevated LFTs (1.1 %)


RASP: Bronchospasm


 

Cautions:

Precautions:

Anesthesia/surgery (myocardial depression),avoid abrupt withdrawal; bronchospastic airways, congestive heart failure;diabetes mellitus, hyperthyroidism/thyrotoxicosis,concurrent clonidine (discontinue several days prior to withdrawal of clonidine), peripheral vascular disease, renal disease.


Pregnancy, breast-feeding: & old age: Use with caution.


 

Interaction:

Drugs 


Alfa-1 adrenergic blockers: Potential enhanced first dose response (marked initial drop in blood pressure, particularly on standing)


Amiodarane: Symptomatic bradycardia and sinus arrest; AV node refractory period prolonged and sinus node automaticity decreased, especially patients with bradycardia, sick sinus syndrome, or partial AV


Benzodiazepines: Increased benzodiazepine activity


Cimetidine: Via inhibition of hepatic metabolism, cimetidine increases many ß-blocker serum concentrations


Clonidine: Withdrawal of clonidine abruptly may exaggerate the hypertension due to unopposed alpha- stimulation; safer than other beta-blockers, however


Digoxin: Additive prolongation of atrioventricular (AV) conduction time


Dihydropyridine calcium channel blockers: Severe hypotension or impaired cardiac performance; most prevalent with impaired left ventricular function,cardiac arrhythmias, or aortic stenosis


Diltiazem: Potentiates beta-adrenergic effects; hypotension, left ventricular failure, and AVconduction disturbances problematic in elderly,patients with left ventricular dysfunction, aortic stenosis, or with large doses of either drug


Hypoglycemic agents: Masked hypoglycemia,hyperglycemia


Nonsteroidal antiinflammatory drugs: Reduced antihypertensive effect


Rifampin: 70% decrease in carvedilol concentrations


Verapamil: Potentiates beta-adrenergic effects; hypotension, left veconduction disturbances problematic in elderly, patients with left ventricular dysfunction, aortic stenos is, or with large doses of either drug


 


 

Warnings:

Adverse Effects:

Lactations:

Special Precautions:

Counselling:

Side Effects Or Adverse Reactions:

Patient And Carer Advice: